Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
/in International Publications, Pancreatic Cancer /von 2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-83Dendritic cell immunotherapy for breast cancer
/in Breast Cancer, International Publications /von 2006-06-01 / Expert Opin Biol Ther 2006 Jun;6(6):591-604[Therapeutic effect of whole body hyperthermia combined with chemotherapy in patients with advanced cancer]
/in Gastric Cancer, Hyperthermia, International Publications, NSCLC /von 2006-06-01 / Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006 Jun;31(3):350-2Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial
/in International Publications, Prostate Cancer /von 2006-06-01 / Prostate 2006 Jun;66(8):811-21Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
/in Hypernephroma, International Publications /von 2006-06-01 / Cancer Res. 2006 Jun;66(11):5910-8Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial
/in HIV/AIDS, International Publications /von 2006-06-01 / J. Med. Virol. 2006 Jun;78(6):711-8Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2006-06-01 / Cell. Mol. Immunol. 2006 Jun;3(3):197-203Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2)
/in Chronic Virus Hepatitis, International Publications /von 2006-06-01 / J. Gastroenterol. Hepatol. 2006 Jun;21(6):970-6Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed
/in Cervical Cancer, International Publications /von 2006-06-01 / Int J Hyperthermia 2006 Jun;22(4):353-63
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution